November turned out to be a strong month for equity markets as discussed in this month's newsletter. November's BOTB had some stand out performances as shown in the table below.
Fund % return in November L&G Global Health & Pharmaceuticals Index Trust 4.53 Slater Growth 3.55 AXA Framlington UK Growth 3.47 Marlborough US Multi-Cap Income 3.06 Royal London Sustainable Leaders Trust 2.82 VT Gravis Clean Energy Income 2.62In a month where risk was rewarded, only 5 funds didn't make a profit and these were understandably bond/gilt funds, yet the losses were under 0.5%. December's BOTB continues the recent trend of steadily reducing the selections unhedged US equity exposure despite US equities hitting new all-time highs in dollar terms. Again, this is reflective of a wider trend of reducing the BOTB's currency exposure across its overseas holdings more widely, while at the same time increasing the BOTB's domestic equity exposure.
Full article available exclusively to 80-20 Investor members.
To read the complete article, sign up for a free trial or log in below.
Start a free trial Already have an account? Log in
